Journal
ONCOLOGIST
Volume 26, Issue 8, Pages E1460-E1469Publisher
OXFORD UNIV PRESS
DOI: 10.1002/onco.13750
Keywords
Plasminogen activator urokinase receptor; Glioma; Prognosis; Immune response; Immunosuppressive phenotype
Categories
Funding
- National Natural Science Foundation of China [81802994]
- National Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) Joint Research Scheme [81761168038]
- Beijing Municipal Administration of Hospitals' Mission Plan [SML20180501]
- Beijing Nova Program [Z171100001117022]
Ask authors/readers for more resources
The study revealed the clinical significance of plasminogen activator urokinase receptor (PLAUR) in gliomas, providing insights into immunosuppressive effects and potential implications for immunotherapy. High PLAUR expression was associated with immune response, infiltration of macrophages, and immunosuppressive markers, suggesting PLAUR as a potential marker for treatment decisions and predicting patient outcomes.
Background Clinical outcomes of patients with glioma are still poor, even after standard treatments, including surgery combined with radiotherapy and chemotherapy. New therapeutic strategies and targets for glioma are urgently needed. Plasminogen activator urokinase receptor (PLAUR), a highly glycosylated integral membrane protein, is reported to modulate plasminogen activation and extracellular matrix degradation in many malignant cancers, but its role in gliomas remains unclear. Methods Glioma samples with mRNA sequencing data and clinical information from the Chinese Glioma Genome Atlas (n = 310) data set and The Cancer Genome Atlas (n = 611) data set were collected for this study. Analyses using Kaplan-Meier plots, time-dependent receiver operating characteristic curves, Cox regression, and nomograms were conducted to evaluate the prognostic performance of PLAUR expression. Analyses using Metascape, ESTIMATE, EPIC, and immunohistochemical staining were performed to reveal the potential biological mechanism. The statistical analysis and graphical work were completed using SPSS, R language, and GraphPad Prism. Results PLAUR was highly expressed in phenotypes associated with glioma malignancy and could serve as an independent prognostic indicator. Functional analysis revealed the correlation between PLAUR and immune response. Further studies found that samples with higher PLAUR expression were infiltrated with fewer CD8 T cells and many more M2 macrophages. Strong positive correlation was demonstrated between PLAUR expression and some immunosuppressive markers, including immune checkpoints and cytokines. These findings were also confirmed in patient samples. Conclusion Our results elucidated the clinical significance and immunosuppressive effect of PLAUR in gliomas, which might provide some clues in glioma immunotherapy. Implications for Practice Although the efficacy of immunotherapy has been verified in other tumors, its application in glioma is impeded because of the unique microenvironment. Tumor-associated macrophages, which are particularly abundant in a glioma mass, contribute much to the immunosuppressive microenvironment and offer new opportunities in glioma immunotherapy. The results of this study identified plasminogen activator urokinase receptor (PLAUR) expression as a potential marker to predict the infiltration of macrophages and the status of immune microenvironment in patients with glioma, suggesting that treatment decisions could be based on PLAUR level when administering immunotherapeutics. The soluble PLAUR in blood and other body fluids would make this approach easy to implement in the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available